34 results
424B3
ARTL
Artelo Biosciences Inc
1 Jun 22
Prospectus supplement
9:07pm
promulgated by the U.S. Treasury Department, current administrative interpretations and practices of the U.S. Internal Revenue Service (“IRS
8-K
EX-10.1
3zcfa87v
16 May 22
Entry into a Material Definitive Agreement
8:20am
10-KT
4z158uu6qa9tod
21 Mar 22
Annual report (with FYE transition)
8:32am
8-K
EX-10.1
22yh7ewdszmbp8
9 Apr 21
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-99.2
2gq4g 99d8q1x
14 Oct 20
Artelo Biosciences, Inc. Announces Pricing of $6.6 Million Upsized Underwritten Public Offering
4:15pm
8-K
EX-1.1
c2qw oty7
14 Oct 20
Artelo Biosciences, Inc. Announces Pricing of $6.6 Million Upsized Underwritten Public Offering
4:15pm
8-K
EX-99.1
ges6t8m5
14 Oct 20
Artelo Biosciences, Inc. Announces Pricing of $6.6 Million Upsized Underwritten Public Offering
4:15pm
424B4
heeoi acsg57
13 Oct 20
Prospectus supplement with pricing info
6:18am
8-K
EX-1.1
m1fbe8sz
14 Apr 20
Entry into a Material Definitive Agreement
9:31pm
POS AM
ej1hh33k5j7p ap3f
6 Apr 20
Prospectus update (post-effective amendment)
9:45pm